217 related articles for article (PubMed ID: 25223268)
1. Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012.
Levy A; Sullivan SG; Tempone SS; Wong KL; Regan AK; Dowse GK; Effler PV; Smith DW
Vaccine; 2014 Oct; 32(47):6312-8. PubMed ID: 25223268
[TBL] [Abstract][Full Text] [Related]
2. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
[TBL] [Abstract][Full Text] [Related]
3. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
[TBL] [Abstract][Full Text] [Related]
4. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China.
Yang P; Thompson MG; Ma C; Shi W; Wu S; Zhang D; Wang Q
Vaccine; 2014 Sep; 32(41):5285-9. PubMed ID: 25092635
[TBL] [Abstract][Full Text] [Related]
5. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
[TBL] [Abstract][Full Text] [Related]
6. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.
Martínez-Baz I; Navascués A; Pozo F; Chamorro J; Albeniz E; Casado I; Reina G; Cenoz MG; Ezpeleta C; Castilla J;
Hum Vaccin Immunother; 2015; 11(7):1626-33. PubMed ID: 25996366
[TBL] [Abstract][Full Text] [Related]
7. Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia.
Carville KS; Grant KA; Sullivan SG; Fielding JE; Lane CR; Franklin L; Druce J; Kelly HA
Vaccine; 2015 Jan; 33(2):341-5. PubMed ID: 25448093
[TBL] [Abstract][Full Text] [Related]
8. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
[TBL] [Abstract][Full Text] [Related]
9. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants.
Janjua NZ; Skowronski DM; De Serres G; Dickinson J; Crowcroft NS; Taylor M; Winter AL; Hottes TS; Fonseca K; Charest H; Drews SJ; Sabaiduc S; Bastien N; Li Y; Gardy JL; Petric M
J Infect Dis; 2012 Jun; 205(12):1858-68. PubMed ID: 22492921
[TBL] [Abstract][Full Text] [Related]
10. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
[TBL] [Abstract][Full Text] [Related]
11. Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season.
Rizzo C; Bella A; Alfonsi V; Puzelli S; Palmieri AP; Chironna M; Pariani E; Piatti A; Tiberti D; Ghisetti V; Rangoni R; Colucci ME; Affanni P; Germinario C; Castrucci MR
Vaccine; 2016 Jun; 34(27):3102-3108. PubMed ID: 27154392
[TBL] [Abstract][Full Text] [Related]
12. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
Skowronski DM; Masaro C; Kwindt TL; Mak A; Petric M; Li Y; Sebastian R; Chong M; Tam T; De Serres G
Vaccine; 2007 Apr; 25(15):2842-51. PubMed ID: 17081662
[TBL] [Abstract][Full Text] [Related]
13. Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test-negative study.
Lytras T; Kossyvakis A; Melidou A; Exindari M; Gioula G; Pogka V; Malisiovas N; Mentis A
Vaccine; 2015 Jan; 33(2):367-73. PubMed ID: 25448097
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of seasonal influenza vaccine in Australia, 2015: An epidemiological, antigenic and phylogenetic assessment.
Fielding JE; Levy A; Chilver MB; Deng YM; Regan AK; Grant KA; Stocks NP; Sullivan SG
Vaccine; 2016 Sep; 34(41):4905-4912. PubMed ID: 27577556
[TBL] [Abstract][Full Text] [Related]
15. Seasonal influenza vaccine effectiveness estimates: Development of a parsimonious case test negative model using a causal approach.
Lane CR; Carville KS; Pierse N; Kelly HA
Vaccine; 2016 Feb; 34(8):1070-6. PubMed ID: 26795366
[TBL] [Abstract][Full Text] [Related]
16. Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014.
Sullivan SG; Carville KS; Chilver M; Fielding JE; Grant KA; Kelly H; Levy A; Stocks NP; Tempone SS; Regan AK
Epidemiol Infect; 2016 Aug; 144(11):2317-28. PubMed ID: 27125368
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
[TBL] [Abstract][Full Text] [Related]
18. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
[TBL] [Abstract][Full Text] [Related]
19. Influenza vaccine effectiveness in the tropics: moderate protection in a case test-negative analysis of a hospital-based surveillance population in Bangkok between August 2009 and January 2013.
Levy JW; Simasathien S; Watanaveeradej V; Bhoomiboonchoo P; Fernandez S; Jarman RG; Klungthong C; Gibbons RV; Kerdpanich P; Piboonbanakit D; Chirabandhu T; Yoon IK
PLoS One; 2015; 10(8):e0134318. PubMed ID: 26267430
[TBL] [Abstract][Full Text] [Related]
20. Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match.
Sullivan SG; Komadina N; Grant K; Jelley L; Papadakis G; Kelly H
J Med Virol; 2014 Jun; 86(6):1017-25. PubMed ID: 24395730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
